| Title : Evaluation of Teneligliptin a DPP4 Inhibitor in Terms of Efficacy and Safety with Respect to QT\/QTc Prolongation in Patients with Type II Diabetes Mellitus (T2DM) - Bhosle_2022_J.Assoc.Physicians.India_70_11 |
| Author(s) : Bhosle D , Chandekar B , Alimuddin S |
| Ref : J Assoc Physicians India , 70 :11 , 2022 |
| Abstract : Bhosle_2022_J.Assoc.Physicians.India_70_11 |
| ESTHER : Bhosle_2022_J.Assoc.Physicians.India_70_11 |
| PubMedSearch : Bhosle_2022_J.Assoc.Physicians.India_70_11 |
| PubMedID: 35598125 |
Bhosle D, Chandekar B, Alimuddin S (2022)
Evaluation of Teneligliptin a DPP4 Inhibitor in Terms of Efficacy and Safety with Respect to QT\/QTc Prolongation in Patients with Type II Diabetes Mellitus (T2DM)
J Assoc Physicians India
70 :11
Bhosle D, Chandekar B, Alimuddin S (2022)
J Assoc Physicians India
70 :11